"Hypotyrosinemia" in phenylketonuria.

It has been postulated that the significant incidence of learning disabilities in well-treated patients with phenylketonuria (PKU) may be due, in part, to reduced production of neurotransmitters as a result of deficient tyrosine transport across the neuronal cell membrane. Hypotyrosinemia has been reported in treated and untreated PKU but virtually no data are available. We decided to examine this in our patient population and to compare it with the published norms, patient data from our hospital clinical biochemical laboratory database, and a group of normal children and adolescents in a private pediatric practice. We found that the mean nonfasting plasma tyrosine in 99 classical PKU patients was 41.1 micromol/L, in 26 mild (atypical) PKU patients 53.3 micromol/L, and in 35 non-PKU mild hyperphenylalaninemia patients 66.6 micromol/L. This compared to nonfasting plasma tyrosine levels in 102 non-PKU subjects of 64.0 micromol/L in our hospital biochemistry database, 69.1 micromol/L in 58 volunteers in the private office practice, and 64-78.8 micromol/L in infants, children, and adolescents in the literature review. Our data support the previously undocumented statements in the literature that plasma tyrosine levels are low in PKU.
AuthorsW B Hanley, A W Lee, A J Hanley, D C Lehotay, V J Austin, W E Schoonheyt, B A Platt, J T Clarke
JournalMolecular genetics and metabolism (Mol Genet Metab) Vol. 69 Issue 4 Pg. 286-94 (Apr 2000) ISSN: 1096-7192 [Print] UNITED STATES
PMID10870846 (Publication Type: Journal Article)
Chemical References
  • Tyrosine
  • Phenylalanine
  • Adolescent
  • Adult
  • Analysis of Variance
  • Child
  • Humans
  • Infant
  • Infant, Newborn
  • Phenylalanine (blood)
  • Phenylketonurias (blood, pathology)
  • Review Literature as Topic
  • Severity of Illness Index
  • Tyrosine (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: